We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 666

The Issues 2014 - upcoming legal topics in the Czech Republic
  • CMS Cameron McKenna
  • Czech Republic, European Union
  • January 24 2014

Since the summer, M&A practitioners across Europe have been talking about their ‘cautiously optimistic’ forecast for the markets. The first two


Canada-Europe Free Trade Agreement: a new prescription for drug patents in Canada
  • DLA Piper LLP
  • Canada, European Union
  • October 31 2013

On October 17, Canadian Prime Minister Stephen Harper flew to Brussels to conclude a Comprehensive Economic and Trade Agreement ("CETA"), or free


A summary of major developments in key areas - general counsel update - July 2014
  • Herbert Smith Freehills LLP
  • Australia, European Union, Hong Kong, United Kingdom
  • July 15 2014

Legislation, in the form of a Regulation and Directive, has been published in the Official Journal of the European Union which will substantially


Johnson & JohnsonNovartis another challenge to pay for delay: is this ever permissible?
  • Bryan Cave LLP
  • European Union, France, Germany, Italy, United Kingdom
  • January 14 2014

In the latest challenge to so-called “pay for delay” or “reverse payment” agreements, on 10 December 2013, the European Commission fined the


ECJ Damgaard on advertising by third party
  • NautaDutilh
  • Denmark, European Union
  • April 21 2009

On 2 April 2009, the European Court of Justice (ECJ) rendered its judgment in the Damgaard case


Global corporate insurance & regulatory bulletin
  • Mayer Brown JSM
  • China, European Union, United Kingdom, USA
  • December 5 2013

The China Insurance Regulatory Commission (“CIRC”) announced new rules (Implementing Rules of Provisional Measures on Outbound Investments with


Draft regulation on clinical trials - abolishment of obligatory insurance
  • Bird & Bird
  • European Union
  • February 25 2013

In July 2012 the European Commission published its proposal for a "Regulation on clinical trials on medicinal products for human use" (COM 2012 369


Sidley Austin LLP global pricing newsletter - volume three 2014
  • Sidley Austin LLP
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare


Actualidad Normativa N.º 8
  • Gómez-Acebo & Pombo Abogados
  • European Union, Spain
  • July 21 2014

En materia medioambiental consideramos de interés las siguientes normas: El Real Decreto 1632014, de 14 de marzo, por el que se crea el Registro de


EC-funded research suggests approach to insuring nanomaterial production risk
  • Shook Hardy & Bacon LLP
  • European Union
  • April 5 2013

In a Nature Nanotechnology commentary titled "The insurability of nanomaterial product risk," business and scientific researchers funded by the